Use of Systemic Treatment in Patients with Chronic Pruritus: A Survey of Dermatologists in the Netherlands by Tessa A. Kouwenhoven, Peter C.M. van de Kerkhof, Marijke Kamsteeg

Get full text

Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients. by Patrick L J M Zeeuwen, Gys J de Jongh, Diana Rodijk-Olthuis, Marijke Kamsteeg, Renate M Verhoosel, Michelle M van Rossum, Pieter S Hiemstra, Joost Schalkwijk

Get full text

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry by Celeste M. Boesjes, Liana F. van der Gang, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Marlies de Graaf, Marjolein S. de Bruin-Weller

Get full text

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry by Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, Marijke Kamsteeg, Inge Haeck, Anneke M.T. van Lynden-van Nes, Klaziena Politiek, Liana F. van der Gang, Marlies de Graaf, Marjolein S. de Bruin-Weller, Marie L.A. Schuttelaar

Get full text

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis by Lotte S. Spekhorst, Marlies deGraaf, Lisa P. van derRijst, Nicolaas P. A. Zuithoff, René C. Schweizer, Marijke Kamsteeg, Inge Haeck, Anneke M. T. vanLynden‐van Nes, Paula vanLumig, Geertruida L. E. Romeijn, Marie‐Louise Schuttelaar, Marjolein S. deBruin‐Weller

Get full text

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry by Celeste M. Boesjes, Esmé Kamphuis, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Laura Loman, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Anneke M.T. van Lynden-van Nes, Floor M. Garritsen, Klaziena Politiek, Marja Oldhoff, Marlies de Graaf, Marie L.A. Schuttelaar, Marjolein S. de Bruin-Weller

Get full text

Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. by Patrick A M Jansen, Diana Rodijk-Olthuis, Edward J Hollox, Marijke Kamsteeg, Geuranne S Tjabringa, Gys J de Jongh, Ivonne M J J van Vlijmen-Willems, Judith G M Bergboer, Michelle M van Rossum, Elke M G J de Jong, Martin den Heijer, Andrea W M Evers, Mieke Bergers, John A L Armour, Patrick L J M Zeeuwen, Joost Schalkwijk

Get full text